![Joanne Donovan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joanne Donovan
Chief Tech/Sci/R&D Officer at
EDGEWISE THERAPEUTICS, INC.
Net worth: 177 431 $ as of 2026-06-29
Profile
Joanne M.
Donovan is currently Chief Medical Officer at Edgewise Therapeutics, Inc. since 2021.
Formerly, Dr. Donovan was Medical Director at GelTex Pharmaceuticals, Inc., Chief Medical Officer & SVP-Clinical Development at Astria Therapeutics, Inc. from 2011 to 2021, Associate Clinical Professor at Harvard Medical School, and Vice President-Clinical Development at Genzyme Corp.
from 1998 to 2011.
Education includes undergraduate, graduate, and doctorate degrees from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-04 | 4,367 ( 0% ) | 177 431 $ | 2026-06-29 |
Joanne Donovan active positions
| Companies | Position | Start |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-04-26 |
Former positions of Joanne Donovan
| Companies | Position | End |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-04-22 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Chief Tech/Sci/R&D Officer | 2011-06-30 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Chief Tech/Sci/R&D Officer | - |
Training of Joanne Donovan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edgewise Therapeutics, Inc.
 Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
- Stock Market
- Insiders
- Joanne Donovan
